These lab-produced alternate options weren't developed with leisure use in mind. During the nineties, John W. Huffman along with a crew of fellow chemists at Clemson College established many of the first formulation for artificial cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts